Mydrin-P Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

This drug has not been investigated (drug use investigation etc.) to determine the incidence of adverse reactions. If systemic symptoms are observed, administration should be discontinued.
Clinically significant adverse reactions: Shock and anaphylaxis (incidence unknown): Since shock and anaphylaxis may occur, patients should be carefully observed. If any symptoms such as erythema, rash, dyspnoea, decreased blood pressure, and eyelid oedema, etc. are observed, administration should be discontinued and appropriate measures should be taken.
Other adverse reactions: If the following adverse reactions are observed, appropriate measures such as discontinuing administration should be taken. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Mydrin-P Adverse Reactions

Manufacturer:

Santen

Distributor:

The Glory Medicina

DKSH

Yu Chun